Impact of Polysaccharides from Traditional Chinese Medicine on Rheumatoid Arthritis via Gut Microbiota Alteration: A Systematic Review of Animal Studies - Scorecard - MDSpire
Advertisement
Impact of Polysaccharides from Traditional Chinese Medicine on Rheumatoid Arthritis via Gut Microbiota Alteration: A Systematic Review of Animal Studies
Clinical Scorecard: Impact of Polysaccharides from Traditional Chinese Medicine on Rheumatoid Arthritis via Gut Microbiota Alteration: A Systematic Review of Animal Studies
At a Glance
Category
Detail
Condition
Rheumatoid Arthritis (RA)
Key Mechanisms
Modulation of gut microbiota, enhancement of SCFA production, suppression of inflammatory pathways.
Target Population
Animal models of rheumatoid arthritis.
Care Setting
Research and experimental studies.
Key Highlights
TCMPs significantly alleviate RA symptoms and improve bone quality metrics.
Modulation of gut microbiota leads to increased abundance of beneficial bacteria.
TCMPs correlate with reduced pro-inflammatory cytokines and enhanced SCFA levels.
Mechanistic pathways include suppression of NF-κB and JAK/STAT3 pathways.
Future research should focus on rigorous study designs and clinical translation.
Guideline-Based Recommendations
Diagnosis
Utilize clinical criteria for diagnosing rheumatoid arthritis.
Management
Consider TCMPs as alternative therapeutic agents for RA.
Monitoring & Follow-up
Monitor changes in gut microbiota and inflammatory markers.
Risks
Be aware of potential adverse effects of conventional RA treatments.
Patient & Prescribing Data
Animal models used in studies.
TCMPs show promise in modulating gut microbiota and alleviating RA symptoms.
Clinical Best Practices
Integrate multi-omics approaches in future research.
Prioritize the study of polysaccharides in clinical settings.
Ten-year observational data showed lower disease activity and functional disability coinciding with broader use of biologic and targeted synthetic therapies.
